| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |